Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function.
Haiyan YuJianping CenXiaoxia LinHao ChengOliver SeifertPublished in: Immunity, inflammation and disease (2021)
This study shows that imiquimod directly inhibits melanogenesis and increases melanocyte apoptosis rates. These effects combined with the upregulation of TLR7 and TLR9 together with increased autophagy activity and inflammatory cytokines production, might be the main reasons leading to hypopigmented lesions after imiquimod application.